New York State Common Retirement Fund
TARS icon

New York State Common Retirement Fund’s Tarsus Pharmaceuticals TARS Stock Holding History

New York State Common Retirement Fund’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47M Buy
39,303
+3,385
+9% +$216K ﹤0.01% 1376
2026
Q1 		$2.52M Sell
35,918
-7,237
-17% -$506K ﹤0.01% 1295
2025
Q4 		$3.53M Sell
43,155
-5,452
-11% -$407K ﹤0.01% 1171
2025
Q3 		$2.89M Buy
48,607
+5,603
+13% +$276K ﹤0.01% 1304
2025
Q2 		$1.74M Hold
43,004
– – ﹤0.01% 1459
2025
Q1 		$2.21M Hold
43,004
– – ﹤0.01% 1338
2024
Q4 		$2.38M Sell
43,004
-1,600
-4% -$72.7K ﹤0.01% 1357
2024
Q3 		$1.47M Buy
44,604
+5,105
+13% +$143K ﹤0.01% 1512
2024
Q2 		$1.07M Buy
39,499
+20
+0.1% +$672 ﹤0.01% 1728
2024
Q1 		$1.44M Buy
39,479
+12,961
+49% +$381K ﹤0.01% 1600
2023
Q4 		$537K Sell
26,518
-48
-0.2% -$801 ﹤0.01% 2068
2023
Q3 		$472K Buy
26,566
+15,724
+145% +$278K ﹤0.01% 2076
2023
Q2 		$196K Sell
10,842
-2,123
-16% -$33.8K ﹤0.01% 2507
2023
Q1 		$163K Hold
12,965
– – ﹤0.01% 2672
2022
Q4 		$190K Buy
12,965
+17
+0.1% +$281 ﹤0.01% 2742
2022
Q3 		$222K Buy
12,948
+88
+0.7% +$1.4K ﹤0.01% 2732
2022
Q2 		$188K Buy
12,860
+6,979
+119% +$105K ﹤0.01% 2819
2022
Q1 		$99K Buy
5,881
+9
+0.2% +$167 ﹤0.01% 3021
2021
Q4 		$132K Sell
5,872
-9
-0.2% -$234 ﹤0.01% 3010
2021
Q3 		$127K Sell
5,881
-3,472
-37% -$85.9K ﹤0.01% 3066
2021
Q2 		$271K Buy
9,353
+3,453
+59% +$108K ﹤0.01% 2907
2021
Q1 		$190K Buy
5,900
+2,400
+69% +$88.7K ﹤0.01% 2854
2020
Q4 		$145K Buy
+3,500
New +$99.7K ﹤0.01% 2870

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

New York State Common Retirement Fund's TARS Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Tarsus Pharmaceuticals (TARS) stake by 9.4% in Q2 2026, buying an estimated $216K and bringing the position to 39,303 shares worth $2.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1376.

New York State Common Retirement Fund first reported a position in TARS in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.53M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • New York State Common Retirement Fund held 39,303 shares of Tarsus Pharmaceuticals worth $2.47M as of Q2 2026.
  • New York State Common Retirement Fund bought 3,385 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $216K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1376 holding.
  • New York State Common Retirement Fund first reported a position in Tarsus Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • New York State Common Retirement Fund's Tarsus Pharmaceuticals position peaked at $3.53M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.